CIK 0001737953 · Non-accelerated filer<br>Smaller reporting company
Replimune Group, Inc.
Sign in to watch- Ticker
- REPL
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Mar 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 822082553
- Phone
- (781) 222-9600
- Business address
- 500 UNICORN PARK, WOBURN, MA, 01801
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $654,036
- in 3 filings
Net −$654,036. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-05-16 | Coffin Robert President & Chief R&D Officer | Sale | −7,861 | $18.05 | $142K | 1,833,336 |
| 2023-05-16 | Lewis Tanya Chief Dev. Op. Officer | Sale | −12,207 | $18.05 | $220K | 148,153 |
| 2023-05-16 | Love Colin Chief Operating Officer | Sale | −10,775 | $18.05 | $194K | 794,960 |
Page 8 of 8 · 143 trades